Estados Unidos · Plataformas y datos · MarketBeat

Merck Highlights Phase III Cancer Wins, Eyes 2027 Oncology Pipeline Catalysts

Publicado por MarketBeat · Estados Unidos hace 2 h

Merck & Co., Inc. (NYSE:MRK) outlined new oncology data and development plans at the European Society for Medical Oncology annual meeting, highlighting phase III results for its…

Leer el artículo completo en MarketBeat Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketbeat.com)

Merck Highlights Phase III Cancer Wins, Eyes 2027 Oncology Pipeline Catalysts

También te puede interesar

Own Costco Stock by Oct. 30 to Qualify for Its Nov. 13 Dividend. Here's How Many Shares You'd Need for $1,000 in Yearly Dividends.

SPACCircle Acquisition prices $100M IPO on Nasdaq

‘You need only watch episodes of Judge Judy’: I’m in my 70s. Why do people keep making the same avoidable financial mistakes?

Banks are locking AI agents out, Hashgraph CIO Gregg Bell says blockchain is the way back in

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Market News

Merck Highlights Phase III Cancer Wins, Eyes 2027 Oncology Pipeline Catalysts

Compartir

También te puede interesar

Own Costco Stock by Oct. 30 to Qualify for Its Nov. 13 Dividend. Here's How Many Shares You'd Need for $1,000 in Yearly Dividends.

SPACCircle Acquisition prices $100M IPO on Nasdaq

‘You need only watch episodes of Judge Judy’: I’m in my 70s. Why do people keep making the same avoidable financial mistakes?

Banks are locking AI agents out, Hashgraph CIO Gregg Bell says blockchain is the way back in

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Market News